Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 14Unknown 7Terminated 2Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Prostatic Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Arthritis 1Adenomatous Polyps 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Walking × Clear all
NCT02139774 2015-12-04

Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer

UNC Lineberger Comprehensive Cancer Center

Terminated
15 enrolled
EndocrineGenitourinary

Arthritis, Motor Activity, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT01476631 2013-08-05

Step Down Colon Cancer Risk

Washington University School of Medicine

Phase NA Terminated
17 enrolled

Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡